Apr 7, 2020 12:45 AM
BACK TO TOP
KSE100
30,579.15
-1042.64
(-3.30%)
ALLSHR
22,022.22
-493.37
(-2.19%)
KSE30
13,526.01
-488.74
(-3.49%)
KMI30
48,022.16
-1700.37
(-3.42%)
BKTi
10,469.41
-386.11
(-3.56%)
OGTi
11,191.63
-48.50
(-0.43%)
KMIALLSHR
14,589.99
-415.01
(-2.77%)
UPP9
9,471.92
-397.42
(-4.03%)
NITPGI
7,134.15
-218.18
(-2.97%)
AGP Limited
PHARMACEUTICALS
Rs.81.35
-3.43
(-4.05%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Apr 6, 2020 3:01 PM
REG
FUT
ODL
Open
82.35
High
85.75
Low
81.00
Volume
11,000
CIRCUIT BREAKER
78.42 — 91.14
DAY RANGE
81.00 — 85.75
52-WEEK RANGE
51.06 — 112.18
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
84.78
VAR
25.00
HAIRCUT
32.50
P/E Ratio (TTM)
15.74
1-Year Change *
-0.20%
YTD Change *
-18.12%
Open
86.86
High
88.00
Low
86.86
Close
88.00
Change
3.80%
LDCP
84.78
Volume
11
Total Trades
2
CIRCUIT BREAKER
76.30 — 93.26
DAY RANGE
86.86 — 88.00
Ask Price
86.00
Ask Volume
49
Bid Price
81.00
Bid Volume
100
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

AGP Limited was incorporated as a public limited company in May 2014 under the repealed Companies Ordinance. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale and manufacturing of pharmaceutical products. The Company is subsidiary of OBS Pakistan and the Ultimate Parent Company is West End 16 Pte Limited - Singapore.

KEY PEOPLE
Mr Tariq Moinuddin KhanChairman
Ms Nusrat MunshiCEO
Mr.Umair MukhtarCompany Secretary
ADDRESS

B-23-C, S.I.T.E, Karachi

WEBSITE

www.agp.com.pk

REGISTRAR

CDC Share Registrar Services Limited

AUDITOR

EY Ford Rhodes Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
22,778,000.00
Shares
280,000,000
Free Float
84,000,000
Free Float
30.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Mar 13, 2020Financial Results for the Year Ended December 31, 2019 View   PDF
Oct 30, 2019Transmission of Quarterly Report for the period ended September 30, 2019 View   PDF
Oct 30, 2019Financial Results for the Third Quarter ended September 30, 2019 View   PDF
Aug 29, 2019Transmission of Half yearly and Quarterly Report for the period ended June 30, 2019 View   PDF
Aug 6, 2019Financial Results for the half year and quarter ended June 30, 2019 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the period ended March 31, 2019 View   PDF
Apr 26, 2019Financial Results for the quarter ended March 31, 2019 View   PDF
Mar 6, 2019Financial Results for the year ended December 31, 2018 View   PDF
Mar 5, 2019Financial Results for the year ending December 31, 2018 View   PDF
Oct 31, 2018Transmission of Third Quarterly Report for the Period Ended September 30, 2018 View   PDF
DateTitleDocument
Mar 30, 2020Postponement of 6th Annual General Meeting (AGM) View   PDF
Mar 12, 2020Board Meeting in Progress View   PDF
Mar 3, 2020Board Meeting View   PDF
Dec 11, 2019Board Meeting in Progress View   PDF
Dec 4, 2019Board Meeting Other Than Financial Results View   PDF
Oct 29, 2019Board Meeting In Progress View   PDF
Oct 21, 2019Board Meeting View   PDF
Aug 5, 2019Board Meeting in Progress View   PDF
Jul 29, 2019Board Meeting for the half year ended June 30, 2019 View   PDF
Apr 25, 2019Board Meeting in Progress View   PDF
DateTitleDocument
Dec 19, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Dec 12, 2019Approval of Annual Budget View   PDF
Nov 22, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Oct 21, 2019Change of Company Secretary View   
Oct 10, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Oct 3, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Sep 13, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Sep 5, 2019Credit of Interim Cash Dividend View   PDF
Sep 4, 2019Prior notice of payment of interim cash dividend View   PDF
Sep 3, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales6,253,2395,382,0554,724,9904,205,750
Profit after Taxation1,446,3881,206,6901,233,9041,087,080
EPS5.174.314.413.88
Q3 2019Q2 2019Q1 2019
Sales1,401,8491,558,5451,611,009
Profit after Taxation320,734317,800425,297
EPS1.151.131.52
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)58.5256.5060.8358.49
Net Profit Margin (%)23.1322.4226.1125.85
EPS Growth (%)19.95(2.27)13.66
PEG0.96(8.95)

Payouts

DateFinancial ResultsDetailsBook Closure
March 13, 2020 3:07 PM31/12/2019(YR) 20%(F) (D) -
August 6, 2019 3:32 PM30/06/2019(HYR) 12.50%(i) (D) 23/08/2019 - 29/08/2019
April 27, 2018 10:50 AM31/03/2018(IQ) 12.50% (D) 25/05/2018 - 01/06/2018

Financial Reports